Professor Bongani Mayosi spoke to The Conversation about the significance of the discovery of a gene that’s responsible for an inherited form of heart muscle disease.
The emergence of drug resistant tuberculosis has resulted in scientists taking a more aggressive and urgent approach to research into the development of the disease.
UCT has partnered with BGM Pharma and the South African Nuclear Energy Corporation to develop GluCAB, a breakthrough in cancer diagnosis and treatment.
Matthew Amoni always wanted to be a doctor, but he also fell in love with science at school. So he studied both, completing an MBChB, BSc (Med) (Hons) and an MSc in physiology as part of UCT’s Clinical Scholars Programme. And he’s about to start his PhD in heart arrhythmias.